‘Novavax Vaccine Filing Guidance Unchanged, Spokeswoman Says’ – Tweet By Zach Biotech
https://twitter.com/zbiotech/status/1465410202799329283
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant
Novavax Inc (NASDAQ: NVAX) said it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa.
‘Technical paper on the #COVID19 variant of concern, Omicron. It includes a set of preparedness actions for countries’ – World Health Organization
https://twitter.com/WHO/status/1465262222947627012
Looking At Novavax’s Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax.
Looking at options history for Novavax (NASDAQ:NVAX) we detected 41 strange trades.
64 Stocks Moving In Friday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.
The Daily Biotech Pulse: NRx’s Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours.
Recap: Novavax Q3 Earnings
Novavax (NASDAQ:NVAX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM.
Here's what investors need to know about the announcement.